Related Experiment Video
Updated: Jun 14, 2026

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
p66Shc is indispensable for phenethyl isothiocyanate-induced apoptosis in human prostate cancer cells
1Department of Pharmacology and Chemical Biology, and University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.
Abstract:
Naturally occurring phenethyl isothiocyanate (PEITC) selectively inhibits growth of cancer cells by causing apoptosis, but the mechanism of cell death induction is not fully understood. We now show, for the first time, that growth factor adapter protein p66(Shc) is indispensable for PEITC-induced apoptosis. Mouse embryonic fibroblasts derived from p66(Shc) knockout mice were significantly more resistant to PEITC-mediated growth inhibition, cytoplasmic histone-associated apoptotic DNA fragmentation, and caspase-3 activation compared with wild-type fibroblasts. The PEITC treatment resulted in induction as well as increased Ser(36) phosphorylation of p66(Shc) in PC-3 and LNCaP human prostate cancer cells. Knockdown of p66(Shc) protein conferred significant protection against PEITC-mediated cytoplasmic histone-associated DNA fragmentation as well as production of reactive oxygen species in both PC-3 and LNCaP cells. The PEITC-treated PC-3 and LNCaP cells exhibited increased binding of p66(Shc) with prolyl isomerase Pin1, a protein implicated in translocation of p66(Shc) to mitochondria. Consistent with these results, treatment of PC-3 cells with PEITC resulted in translocation of p66(Shc) to the mitochondria as judged by immunoblotting using cytosolic and mitochondrial fractions and immunofluorescence microscopy. Growth suppression and apoptosis induction in tumor xenografts in vivo by oral administration of PEITC to the PC-3 tumor-bearing male athymic mice were accompanied by statistically significant increase in the level of Ser(36)-phosphorylated p66(Shc). Collectively, these results provide novel insight into the critical role of p66(Shc) in regulation of PEITC-induced apoptotic cell death in human prostate cancer cells.
Insights
Phenethyl isothiocyanate (PEITC) induces cancer cell death through apoptosis, a process dependent on the growth factor adapter protein p66(Shc). This protein
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Death Pathways
Background:
- Phenethyl isothiocyanate (PEITC) is a natural compound that selectively inhibits cancer cell growth.
- The precise mechanism by which PEITC induces apoptosis remains incompletely understood.
Purpose of the Study:
- To elucidate the role of growth factor adapter protein p66(Shc) in PEITC-induced apoptosis.
- To investigate the molecular mechanisms linking PEITC treatment, p66(Shc) activation, and cell death in prostate cancer.
Main Methods:
- Utilized p66(Shc) knockout mouse embryonic fibroblasts and prostate cancer cell lines (PC-3, LNCaP).
- Assessed apoptosis via DNA fragmentation and caspase-3 activation assays.
- Investigated p66(Shc) phosphorylation, binding with Pin1, and mitochondrial translocation using Western blotting and immunofluorescence.
- Evaluated PEITC efficacy in vivo using tumor xenograft models in mice.
Main Results:
- p66(Shc) knockout cells showed resistance to PEITC-induced growth inhibition and apoptosis.
- PEITC treatment increased p66(Shc) phosphorylation at Ser(36) and its binding with Pin1 in cancer cells.
- Knockdown of p66(Shc) protected cells against PEITC-induced DNA fragmentation and reactive oxygen species production.
- PEITC induced p66(Shc) translocation to mitochondria and demonstrated in vivo anti-tumor activity.
Conclusions:
- p66(Shc) is essential for PEITC-mediated apoptosis in human prostate cancer cells.
- PEITC's mechanism involves p66(Shc) phosphorylation, Pin1 interaction, and mitochondrial translocation.
- These findings highlight p66(Shc) as a key regulator in PEITC-induced cancer cell death.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Abnormal Proliferation
Caspases
Negative Regulator Molecules